drugset / Trial / NCT01430091
A Relative Bioavailability Study of a Prasugrel Orally Disintegrating Tablet
RandomizedCrossoverOpen-labelTreatment
Summary
This study compares the clinical tablet formulation of prasugrel taken orally with an orally disintegrating tablet (ODT) taken orally. The study will evaluate the amount of prasugrel active metabolite circulating in the blood for each treatment.
Timeline
- Start
- 2011-09
- Primary completion
- 2011-10
- Completion
- 2011-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Prasugrel | Small molecule | 5 mg | Oral |